05 Jan 2011 Medicago announces Publication of its Phase I Study with its Pandemic H5N1 Influenza Virus-Like Particle (VLP) Vaccine Candidate
05 Jan 2011 Profectus BioSciences Announces Initiation of Clinical Trial of IL-12 Enhanced Therapeutic HIV DNA Vaccine Delivered Using Electroporation
05 Jan 2011 Opexa Completes Successful Meetings with FDA to Pursue Phase 3 Clinical Study for Tovaxin in Multiple Sclerosis
04 Jan 2011 ImmunoCellular Therapeutics Receives FDA Approval to Commence Phase II Trial of ICT-107
04 Jan 2011 NOVAVAX Launches Phase I Clinical Trial to Evaluate its Novel Vaccine Against Respiratory Syncytial Virus (RSV)
28 Dec 2010 Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
28 Dec 2010 Emergent BioSolutions Starts Phase I Clinical Trial for Third Generation Anthrax Vaccine
23 Dec 2010 Dynavax Reports Phase 1B Safety and Immunogenicity Results for Hepatitis B Therapy Candidate
23 Dec 2010 US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL
22 Dec 2010 Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13, in Adults 50 and Older
22 Dec 2010 NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate
22 Dec 2010 Medicago updates on progress with Phase II clinical testing of its avian influenza vaccine candidate
21 Dec 2010 The PATH Malaria Vaccine Initiative, Merck and NYU Langone Medical Center Collaborate to Research Potential Malaria Vaccine
21 Dec 2010 Joint Development of Therapeutic Cancer Vaccine WT4869
20 Dec 2010 Phylogica Signs Collaboration and Licensing Deal with Pfizer
16 Dec 2010 NOVAVAX Receives FDA Clearance to Launch Phase I RSV Vaccine Clinical Trial
14 Dec 2010 Profectus Biosciences’ GENEVAX IL-12 Adjuvant Significantly Improves pDNA Vaccine Performance in Phase I Human Trial
13 Dec 2010 Phase III Data Leads Intercell AG to Shelve Late-Stage Traveler’s Diarrhea Vaccine Patch
09 Dec 2010 Bavarian Nordic Receives Special Protocol Assessment Agreement from the FDA for Phase 3 Trial of PROSTVAC
09 Dec 2010 GeoVax Labs: Excellent Safety and Reproducible Immunogenocity Demonstrated in Early Results of Phase 2a Trial for HIV Preventative Vaccine
09 Dec 2010 Argos Therapeutics' Arcelis HIV Immunotherapy Shows Feasibility to Generate Fully Functional Dendritic Cells From Viremic Patients
08 Dec 2010 Preclinical Efficacy of Inovio Pharmaceuticals’ Smallpox DNA Vaccine Featured in The Journal of Infectious Diseases
08 Dec 2010 SEEK Announces Positive Phase I Data for Universal Flu Vaccine at World Influenza Congress
07 Dec 2010 Radient Pharmaceuticals Announces Formation of New Subsidiary NuVax Therapeutics Inc.
07 Dec 2010 Aduro BioTech’s Clinical Results from CRS-207 Phase 1 Trial Presented at AACR Special Conference

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up